Citations

Clear

171 citation(s) found for "Lipton, RB".

Perspectives of Adolescents/Young Adults on the Burden of Their Parent’s Migraine: Results from the CaMEO Study (P4.121)
Buse, Dawn C. , Fanning, Kristina M. , Reed, Michael L. , Adams, Aubrey Manack, Powers, Scott W. , Gelfand, Amy A. , VanderPluym, Juliana H. , Lipton, Richard B.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p4.121 Get It

A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)
Starling, Amaal J. , Tepper, Stewart J. , Shamim, Ejaz A. , Hindiyeh, Nada , Silberstein, Stephen D., Marmura, Michael J. , Robbins, Matthew S. , Charles, Andrew , Goadsby, Peter J. , Lipton, Richard B. , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.004 Get It

Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Dodick, David W. , Goadsby, Peter J. , Lipton, Richard B.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.003 Get It

75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Cady, Roger, Lipton, Richard B. , Dodick, David W. , Goadsby, Peter J.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p2.165 Get It

Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis (1841)
Sommer, Katherine , Silberstein, Stephen D., Diener, Hans‐Christoph , Dodick, David W. , Lipton, Richard B.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1841 Get It

Atogepant Improved Patient-Reported Migraine-Specific Quality of Life in a 12-Week Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine (1459)
Blumenfeld, Andrew , Severt, Lawrence, Stokes, Jonathan , Gandhi, Pranav , Dodick, David W. , Pozo‐Rosich, Patricia , Li, Ye , Lipton, Richard B.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1459 Get It

Atogepant Improved Patient-Reported Outcome (PRO) Measures of Activity Impairment in Migraine-Diary and Headache Impact Test in a 12-Week, Double-blind, Randomized Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine (1454)
Blumenfeld, Andrew , Li, Ye , Severt, Lawrence, Stokes, Jonathan , Gandhi, Pranav , Lipton, Richard B. , Pozo‐Rosich, Patricia , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1454 Get It

Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data from a Phase 3 Clinical Trial (ADVANCE) in Patients with Episodic Migraine (1431)
Gandhi, Pranav , Stokes, Jonathan , Revicki, Dennis A. , Kleinman, Leah , Burk, Caroline , Lipton, Richard B. , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1431 Get It

Improved Functionality, Satisfaction, and Global Impression of Change With Ubrogepant for the Acute Treatment of Migraine in Triptan Insufficient Responders (1247)
Lateiner, Jordan E., Revicki, Dennis A. , Zhao, Sihui, Viswanathan, Hema N., Shewale, Anand R. , Lipton, Richard B. , Singh, Rashmi B. Halker , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1247 Get It

Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO) (870)
Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.870 Get It